[A patient with anti-myelin oligodendrocyte glycoprotein antibody-associated combined central and peripheral demyelination with anti-galactocerebroside and anti-GM1 antibodies].
anti-GM1 antibody
anti-galactocerebroside antibody
anti-myelin oligodendrocyte glycoprotein antibody
combined central and peripheral demyelination
demyelination
Journal
Rinsho shinkeigaku = Clinical neurology
ISSN: 1882-0654
Titre abrégé: Rinsho Shinkeigaku
Pays: Japan
ID NLM: 0417466
Informations de publication
Date de publication:
22 Jul 2023
22 Jul 2023
Historique:
medline:
25
7
2023
pubmed:
3
7
2023
entrez:
2
7
2023
Statut:
ppublish
Résumé
A 48-year-old male was admitted to our hospital because of chronic progressive demyelination of the peripheral nerves of the upper limbs, as well as acute myelitis presenting with sensory disturbance from the left chest to the left leg. We established a diagnosis of combined central and peripheral demyelination (CCPD). The patient was positive for serum anti-myelin oligodendrocyte glycoprotein (MOG), anti-galactocerebroside IgG, and anti-GM1 IgG antibodies. Intravenous methylprednisolone therapy and plasma exchange improved myelitis, and the subsequent administration of oral prednisolone yielded a gradual improvement of the peripheral nerve damage with a mostly negative result for the antibodies. However, the patient experienced a relapse of radiculitis eight months later. Relapses of anti-MOG antibody-associated disease can provoke new immune reactions, leading to CCPD.
Identifiants
pubmed: 37394490
doi: 10.5692/clinicalneurol.cn-001850
doi:
Substances chimiques
Autoantibodies
0
Myelin-Oligodendrocyte Glycoprotein
0
Methylprednisolone
X4W7ZR7023
Immunoglobulin G
0
Types de publication
Case Reports
English Abstract
Journal Article
Langues
jpn
Sous-ensembles de citation
IM